Santos, M. E.Ramiro, S.van der Heijde, D.Landewe, R.2024-10-312024-10-3120240392-856Xhttp://hdl.handle.net/10400.1/26188ASAS and EULAR recommend the use of an improvement ≥1.1 in ASDAS at 12 weeks to determine the continuation of a bDMARD. However, it is debated whether improvements can occur and whether patients’ characteristics influence (time to) response.engconference object1593-098X